A spokesperson for telemedicine platform Midi, which has been advertising GLP-1 microdoses on Instagram, said health risks from being overweight, like cardiovascular disease, can begin at BMIs lower than 27 and the shots have a range of benefits like improving fatty liver disease and easing sleep apnea symptoms
High-Quality Raw Materials: Peptides are formulated using amino acids of the highest purity
Dietary lipids fuel GPX4-restricted enteritis resembling Crohns disease
Those with lower starting body mass index (BMI) or those who lose weight rapidly may notice temperature changes more acutely
Stopping treatment when needed: In certain situations, like pregnancy, pancreatitis, severe allergic reactions, or very low BMI (18.5 or below), treatment may be fully discontinued